Methylation profiles of five genes (APC, CDH13, KLK10, DLEC1, and RASSF1A) in cfDNA of NSCLC patients showed a significantly higher tumor-specific hypermethylation frequency. This evidence concerns the gene RASSF1 and non-small cell lung carcinoma.